Prelude Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-44,300
| Closed | -$403K | – | 1312 |
|
2024
Q1 | $403K | Buy |
+44,300
| New | +$403K | 0.02% | 654 |
|
2020
Q4 | – | Sell |
-200
| Closed | -$2K | – | 1320 |
|
2020
Q3 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 1263 |
|
2020
Q1 | – | Sell |
-56,164
| Closed | -$222K | – | 1374 |
|
2019
Q4 | $222K | Buy |
+56,164
| New | +$222K | 0.01% | 512 |
|